Cargando…

Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p

KRas is mutated in a significant number of human cancers and so there is an urgent therapeutic need to target KRas signaling. To target KRas in lung cancers we used a systems approach of integrating a genome-wide miRNA screen with patient-derived phospho-proteomic signatures of the KRas downstream p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seviour, Elena G., Sehgal, Vasudha, Mishra, Dhruva, Rupaimoole, Rajesha, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Lee, Ju-Seog, Sood, Anil K., Kim, Min P., Mills, Gordon B., Ram, Prahlad T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344721/ https://www.ncbi.nlm.nih.gov/pubmed/27669434 http://dx.doi.org/10.1038/onc.2016.308

Ejemplares similares

Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers
por: Moss, Tyler J, et al.
Publicado: (2015)

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers
por: Sehgal, Vasudha, et al.
Publicado: (2015)

Autocrine Effects of Tumor-Derived Complement
por: Cho, Min Soon, et al.
Publicado: (2014)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)

Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cells
por: McGuire, Michael H., et al.
Publicado: (2019)

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
por: Szymanowska, Anna, et al.
Publicado: (2023)

Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2014)

FABP4 as a key determinant of metastatic potential of ovarian cancer
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Immune cells inhibit the tumor metastasis in the 4D cellular lung model by reducing the number of live circulating tumor cells
por: Mishra, Dhruva K., et al.
Publicado: (2018)

Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis
por: Nagaraja, Archana S., et al.
Publicado: (2015)

Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks
por: Chiu, Hua-Sheng, et al.
Publicado: (2015)

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
por: Wu, Sherry Y., et al.
Publicado: (2016)

Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
por: Seviour, E G, et al.
Publicado: (2016)

Erratum: Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer
por: Seviour, E G, et al.
Publicado: (2016)

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling
por: Haemmerle, Monika, et al.
Publicado: (2017)

A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells
por: Rupaimoole, Rajesha, et al.
Publicado: (2020)

Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer
por: Jin, Xianglan, et al.
Publicado: (2015)

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer
por: Chakraborty, Debaditya, et al.
Publicado: (2021)

Identification of KRAS(G12C) Mutations in Circulating Tumor DNA in Patients With Cancer
por: Thein, Kyaw Z., et al.
Publicado: (2022)

In vivo and in vitro investigation of KIN-193 anti-tumor effects on nasopharyngeal carcinoma
por: Chen, Fuhai, et al.
Publicado: (2020)

The $^{191,193}$Hg and $^{191,193}$Au positon decays
por: Vieu, C, et al.
Publicado: (1976)

Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
por: Morgan, Shethah R., et al.
Publicado: (2012)

KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
por: Kalikaki, Aristea, et al.
Publicado: (2014)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
por: Kondo, Yuurin, et al.
Publicado: (2017)

Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells
por: Feng, Chengbao, et al.
Publicado: (2020)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

193. Comparison of Survival for MSSA and MRSA Endocarditis
por: Kanyo, Emese, et al.
Publicado: (2019)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2019)

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013)

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients
por: GUTIÉRREZ, CRISTINA, et al.
Publicado: (2013)

Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer
por: Takayama, Yuji, et al.
Publicado: (2018)

An enzymatic on/off switch‐mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA
por: Wang, Qing‐lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_im1cfbv53icic8uq20ep81me3b